Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

Indian weddings are a global sensation for all the taam-jhaam—the outfits, the music, the madness, and the unmatched vibe. In an ever-evolving culture, several new trends become a part of the wedding buzz in India. At a time when weight-loss drugs are the talk of the town, it is no surprise that they, too, have joined the list of new must-haves for Indian brides. For many soon-to-be brides and grooms, the pressure to look a class apart is always high. Amid the madness of wedding preparations, brides and grooms often miss the gym—weight-loss drugs come to their rescue.

India's Mounjaro brides

Clinics in metropolitan cities like Delhi and Mumbai are introducing weight-loss treatments into their traditional pre-bridal and bridal packages. Bridal packages initially focused on hair care, skincare, hair styling, and grooming—but they have now expanded to include shots of Mounjaro, a popular weight-loss drug. Some wellness centres in the city have advertised that they offer customised programmes combining workout routines, nutrition, and medication to help clients achieve desired results.

Doctors have noticed a clear rise in such inquiries. Several specialists report that a significant portion of their patients seeking obesity treatments are engaged couples working within a fixed timeline. While medical professionals acknowledge this demand, many emphasise that such treatments should only be prescribed when medically appropriate, rather than purely for cosmetic reasons.

Read more: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

The pressures of looking good at a wedding

Weddings in India are deeply rooted in tradition, elaborate, and often burdened by societal expectations around appearance. As a result, many resort to glycolic treatments, injections of Mounjaro, and sometimes even facial procedures for a bridal glow. However, weight-loss drugs serve a different purpose—they can boost a bride's confidence by helping her feel more comfortable in her own skin.

Others share similar experiences. Some individuals admitted that concerns about body image, often influenced by family expectations or societal standards, played a major role in their decision. In certain cases, weight became a factor in arranged marriage discussions, pushing individuals to seek faster solutions. However, most discontinued the injections shortly after their weddings.

Why are weight-loss drugs becoming so popular?

According to experts, the growing popularity of weight-loss drugs is linked to their increased availability. Globally, pharmaceutical companies have introduced their own versions of obesity treatments in India, and demand has risen drastically. At the same time, more affordable alternatives are being introduced by manufacturers to make these drugs accessible to a wider audience.

A word of caution

Despite the surge, experts warrant caution. Weight-loss drugs are intended to help clinically obese or significantly overweight individuals, as well as patients with type 2 diabetes and hypertension. These drugs are not meant to act as quick fixes for short-term aesthetic goals. Experts, therefore, stress the importance of using these drugs under expert guidance and supervision.

Misuse of weight-loss drugs

Doctors are also concerned about the misuse of weight-loss drugs—health authorities have started monitoring the sale and promotion of such medication, especially the cheaper versions on the market. Experts say that relying solely on these drugs instead of making essential lifestyle changes may not lead to sustainable results. For many, the appeal lies in convenience—maximum benefits with minimal effort. While these drugs may fit into a hectic routine, doctors continue to emphasise the need for a balanced approach to weight loss.

The UK National Health Service (NHS) is soon expected to roll out free weight-loss Wegovy jab to over a million people in England at risk of heart attacks and strokes.

The move is based on the recommendation of the National Institute for Health and Care Excellence (NICE), which said that overweight people with heart problems, or serious circulation problems in their legs, should have the weekly jab "as an extra layer of protection".

Developed by Danish drugmaker Novo Nordisk, Wegovy is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving the weight-loss drug Wegovy sustained weight loss for up to four years.

"We know that people who have already had a heart attack or stroke are living with real fear that it could happen again. The evidence from the clinical trial is compelling. It showed that people taking semaglutide alongside their existing heart medicines were significantly less likely to have another heart attack or stroke,” said Helen Knight, from NICE.

"Today's decision gives thousands of people in that situation an extra layer of protection, on top of the medicines they are already taking," she added.

Also read: Foundayo: US FDA Approves Eli Lilly’s GLP-1 Weight Loss Pill

Wegovy and Heart Risk

A November 2023 study, published in the New England Journal of Medicine, elicited a randomized clinical trial of tens of thousands of people, in which Wegovy - alongside existing heart medicines - was linked to a 20% reduced risk of heart attacks and strokes.

Importantly, benefits were seen early in the clinical trial, before significant weight loss occurred, suggesting the drug works directly on the heart and blood vessels, not just through weight loss, as per the NICE

The BBC reported that the UK faces a significant heart disease burden, and every year:

100,000 people get hospitalized due to heart attacks,

100,000 people experience a stroke

350,000 people live with peripheral arterial disease.

Sharon Hodgson, the health minister, said weight-loss drugs were a “gamechanger” and giving them to people at risk of heart attacks and strokes would be a “lifesaver”.

Also read: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

Wegovy Is Top Weight-Loss Choice for US Teens

Only Wegovy has been approved by the US FDA for children aged 12 and older who are living with obesity. Since the approval in late 2022, the prescriptions have surged.

According to health data company Truveta, which reviewed medical records from 30 US health systems, prescriptions for Wegovy among teens jumped by 50 percent in 2024—rising from 9.9 per 100,000 adolescents in 2023 to 14.8 per 100,000 in 2024.

The first quarter of 2025 showed another increase, with the rate reaching 17.3 per 100,000.

From Europe to Africa to North America to Australia, measles cases are rising across continents. The main driver: declining vaccination rates and immunity gaps.

As of March 26, 1,575 confirmed measles cases were reported in the United States in 2026, according to the latest data published by the US Centers for Disease Control and Prevention.

There have been 16 new outbreaks reported in 2026, and 94% of confirmed cases (1,483 of 1,575) are outbreak-associated (359 from outbreaks starting in 2026 and 1,124 from outbreaks that started in 2025). In 92 percent of cases, measles occurred among those with no vaccination.

Mexico's Ministry of Health recently reported a significant increase in measles cases in 2026, with more than 7,400 confirmed infections recorded since the beginning of the year.

A PAHO report in February shared a 43-fold increase in measles cases across seven countries — Bolivia, Canada, Chile, the United States, Guatemala, Mexico, and Uruguay — with no deaths reported.

Active outbreaks have been reported in London and Birmingham in the UK. In Europe, recurring outbreaks have been reported in Italy, Spain, France and Romania.

A measles alert has also been issued for the Gold Coast area after two cases were confirmed to have been contracted by people overseas and then brought home to Australia.

Earlier this week, Bangladesh reported a measles outbreak that reportedly led to the death of at least 38 children, leading health authorities to roll out a vaccination program for younger children in a bid to halt the outbreak.

Official data show that in 2026, more than 2,300 children were admitted to hospital with suspected measles, of whom 684 have tested positive so far.

Amid these outbreaks, HealthandMe spoke to public health experts to understand whether these cases can increase the risk of the highly contagious disease in India. While India has a better vaccination rate with the Measles and Rubella (MR) Vaccine, some pockets in rural areas may increase the risk.

"In India, the catch-up vaccination drive named Mission Indradhanush was intensified in 2024, successfully rectifying the vaccination gaps that occurred during the COVID pandemic. But the disease can still spread among pockets of the population where vaccination coverage remains low,” Dr. Rajeev Jayadevan, Ex-President of IMA Cochin and Convener of the Research Cell, Kerala, told HealthandMe.

"The proven method to stop measles is to build an 'immunity wall' within the community—by vaccinating at least 95 percent of people—so that the virus repeatedly runs into 'road blocks' and eventually dies out, instead of getting a free ride infecting everyone. When vaccination coverage drops due to many reasons, outbreaks happen, and complications follow," he added.

Also read: Measles In Oahu Visitor Sparks Exposure Risk In Hawaii: Report

What Is Measles?

Measles is a highly contagious virus that spreads through direct contact or through the air when an infected person coughs or sneezes.

Symptoms typically appear seven to 14 days after exposure and may include:

high fever,

cough,

runny nose,

red eyes,

rashes across the body.

Measles And Vaccination

Measles is a vaccine-preventable disease that can cause devastating complications, including blindness, pneumonia, encephalitis, and long-term immune dysfunction.

The reports of deaths from Bangladesh indicate the presence of a significant 'immunity gap,” allowing the virus to take hold, said Dr. Jayadevan. He added that among the unvaccinated, measles is one of the most contagious viruses on Earth—spreading even faster than COVID-19.

Dr Neha Rastogi, Senior Consultant - Infectious Diseases, Fortis Gurugram, told HealthandMe that although the Measles-Rubella (MR) vaccination campaign has played a major role in reducing cases and preventing large-scale outbreaks by building community immunity in India, "there is still some risk of Measles spread in India".

"Although cases have declined significantly, outbreaks can occur due to gaps in vaccination coverage, especially in rural or densely populated areas. Migration, low awareness, and missed immunization doses also contribute to the risk,” she added.

How Does Measles Spread

"Measles spreads rapidly because it is a highly contagious viral disease transmitted through respiratory droplets when an infected person coughs or sneezes," Dr Rastogi told HealthandMe.

She noted that crowded living conditions, poor ventilation, and low immunity levels increase the risk of transmission.

"Lack of awareness, malnutrition (especially vitamin A deficiency), and incomplete or missed vaccination also contribute to outbreaks. The virus can remain active in the air or on surfaces for several hours, making it easy to infect others,” the infectious disease expert said.

The CDC noted that measles transmission may also occur during travel.

"Travelers with fever and other overt signs of transmissible illness, such as coughing or malaise, should be strongly encouraged to delay travel while symptomatic,” it said.

Dr. Jayadevan said that the rising global measles cases are "a reminder that no one is safe until everyone is safe. India must strive to identify those pockets where vaccination coverage is low and undertake intensive corrective measures, taking the community into confidence through effective awareness campaigns".

How To Stay Safe

To safeguard against measles, individuals should ensure timely vaccination, especially for children.

Maintaining good hygiene, such as frequent handwashing and covering the mouth while coughing or sneezing, helps reduce transmission.

Avoiding close contact with infected individuals and ensuring proper nutrition to boost immunity are also important.

Public awareness and community health programs play a crucial role in prevention.